Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

The dysregulation of gene expression is a critical event involved in all steps of tumorigenesis. Aberrant histone and non-histone acetylation modifications of gene expression due to the abnormal activation of histone deacetylases (HDAC) have been reported in hematologic and solid types of cancer. In...

Full description

Bibliographic Details
Main Authors: Dusan Ruzic, Nemanja Djoković, Tatjana Srdić-Rajić, Cesar Echeverria, Katarina Nikolic, Juan F. Santibanez
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
histone deacetylases
cancer
epigenetic
chemoprevention
HDAC inhibitors
dietary-derived inhibitors
Online Access:https://www.mdpi.com/1999-4923/14/1/209

Internet

https://www.mdpi.com/1999-4923/14/1/209

Similar Items